Clinical cohort construction and efficacy evaluation of gouty arthritis with dampness syndrome

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ITMCTR

Registry ID

ITMCTR2100004238

Enrollment

Unknown

Registered

2020-10-11

Start date

2020-10-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gouty arthritis

Interventions

case series:traditional chinese medicine decoction

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients meeting the 2015 ACR / EULAR diagnostic criteria for gouty arthritis. *Gout can be diagnosed if the score is more than 8; 2. Patients who voluntarily participate in case registration study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with secondary gout (Gout Caused by potential diseases or drugs such as aspirin, cyclosporine, diuretics, etc.); 2. Pregnant or lactating women; 3. Patients with severe cardiovascular and cerebrovascular diseases, liver, kidney, malignant tumors, hematopoietic system and mental diseases.

Design outcomes

Primary

Measure	Time frame
eGFR;Cr;UA;CRP;ESR;	—

Secondary

Measure	Time frame
medication safety;TG;GLU;TC;Joint symptoms and signs;General symptoms and signs;	—

Countries

China

Contacts

Public ContactHuang Runyue

Rheumatic immunology research team of Guangdong College of traditional Chinese Medicine

ryhuang@gzucm.edu.cn+86 15889932190

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026